[123I]VIP receptor scintigraphy in patients with pancreatic adenocarcinomas Gregory M. EisenhutJan U. Haberkorn Editorial 17 August 2000 Pages: 1589 - 1590
Does thyroid stunning exist? A model with benign thyroid disease Osama SabriMichael ZimnyUdalrich Buell Original Article 30 August 2000 Pages: 1591 - 1597
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results Markus DietleinKerstin WeberHarald Schicha Original Article 10 October 2000 Pages: 1598 - 1609
Reliability of DMSA for the diagnosis of renal parenchymal abnormality in children Jonathan C. CraigLes IrwigSimon Grunewald Original Article 22 September 2000 Pages: 1610 - 1616
Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET J. MellerG. AltenvoerdeW. Becker Original Article 10 October 2000 Pages: 1617 - 1625
Semi-quantitative evaluation of gallium-67 scintigraphy in lupus nephritis Wan-Yu LinJih-Fang HsiehShyh-Jen Wang Original Article 12 September 2000 Pages: 1626 - 1631
A comparison of the overall first-pass kinetics of thallium-201 and technetium-99m MIBI in normoxic and low-flow ischaemic myocardium Adey AyalewPierre Y. MarieAlain Bertrand Original Article 30 August 2000 Pages: 1632 - 1640
Cardiac sympathetic dysfunction contributes to left ventricular remodelling after acute myocardial infarction K. SakataM. MochizukiH. Tamekiyo Original Article 10 October 2000 Pages: 1641 - 1649
Non-invasive assessment of the effect of cardiac sympathetic innervation on metabolism of the human heart Frank M. BengelPeter UeberfuhrMarkus Schwaiger Original Article 10 October 2000 Pages: 1650 - 1657
Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy Jong Doo LeeHee-Joung KimMin Jung Kim Original Article 06 September 2000 Pages: 1658 - 1665
Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457 – a test-retest analysis Harry VilkmanJaana KajanderJarmo Hietala Original Article 09 September 2000 Pages: 1666 - 1673
[11C]Flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification Sandra M. Sanabria-BohórquezDaniel LabarClaude Veraart Original Article 01 September 2000 Pages: 1674 - 1683
Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours Carsten HesseniusMichael BäderBertram Wiedenmann Original Article 19 August 2000 Pages: 1684 - 1693
Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study Christophe Van de WieleFilip DumontRudi Andre Dierckx Original Article 07 September 2000 Pages: 1694 - 1699
Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA Yu-Min ZhangNing LiuDonald J. Hnatowich Original Article 10 October 2000 Pages: 1700 - 1707
"FUR" – one size suits all Michael RutlandLorna QueIbrahim M. Hassan Original Article 30 August 2000 Pages: 1708 - 1713
Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography Paul D. ActonPhilipp T. MeyerHank F. Kung Short Communication 06 September 2000 Pages: 1714 - 1718
Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB S. HouleN. GinovartA.A. Wilson Short Communication 23 September 2000 Pages: 1719 - 1722
Imaging the glutamatergic system in vivo – relevance to schizophrenia Rodrigo A. BressanLyn S. Pilowsky Review Article 10 October 2000 Pages: 1723 - 1731
Quantifying the radiation exposure of nursing staff delivering hyperbaric oxygen therapy to grade IV neuroblastoma patients post 131I-MIBG therapy Gregory J. MelbourneJan P. Lehm Letter to the editor 31 August 2000 Pages: 1732 - 1733